DOSTARLIMAB

Search structure
Synonyms:
Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN
ATC: L01XC40
UNII: P0GVQ9A4S5

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Programmed cell death protein 1 antagonist

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Endometrial Neoplasms 4 D016889 ClinicalTrials
Neoplasms 4 D009369 ClinicalTrials
Colonic Neoplasms 3 D003110 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 3 D002289 ClinicalTrials
Head and Neck Neoplasms 3 D006258 ClinicalTrials
Colonic Neoplasms 3 D003110 ClinicalTrials
Head and Neck Neoplasms 3 D006258 ClinicalTrials
Ovarian Neoplasms 3 D010051 ClinicalTrials
Ovarian Neoplasms 3 D010051 ClinicalTrials
Mesothelioma 2 D008654 ClinicalTrials
Colorectal Neoplasms 2 D015179 ClinicalTrials
Gestational Trophoblastic Disease 2 D031901 ClinicalTrials
Penile Neoplasms 2 D010412 ClinicalTrials
Rectal Neoplasms 2 D012004 ClinicalTrials
Carcinoma, Pancreatic Ductal 2 D021441 ClinicalTrials
Sarcoma 2 D012509 ClinicalTrials
Melanoma 2 D008545 ClinicalTrials
Rectal Neoplasms 2 D012004 ClinicalTrials
Liver Neoplasms 2 D008113 ClinicalTrials
Uterine Cervical Neoplasms 2 D002583 ClinicalTrials
Small Cell Lung Carcinoma 2 D055752 ClinicalTrials
Pancreatic Neoplasms 2 D010190 ClinicalTrials
Hemangiosarcoma 2 D006394 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Hereditary Breast and Ovarian Cancer Syndrome 2 D061325 ClinicalTrials
Carcinoma 2 D002277 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Uterine Cervical Neoplasms 2 D002583 ClinicalTrials
Carcinoma, Squamous Cell 1 D002294 ClinicalTrials
Multiple Myeloma 1 D009101 ClinicalTrials
Adenocarcinoma, Clear Cell 1 D018262 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4298124
FDA SRS P0GVQ9A4S5
CONTENTS